Docetaxel and atrasentan versus docetaxel and placebo for...

The Lancet Oncology 2013 / 08 Vol. 14; Iss. 9

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

Quinn, David I, Tangen, Catherine M, Hussain, Maha, Lara, Primo N, Goldkorn, Amir, Moinpour, Carol M, Garzotto, Mark G, Mack, Philip C, Carducci, Michael A, Monk, J Paul, Twardowski, Przemyslaw W, Van
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70294-8
Date:
August, 2013
File:
PDF, 261 KB
english, 2013
Conversion to is in progress
Conversion to is failed